Nevro Receives 4 Patents for Chronic Pain Device

Written by  Anuja Vaidya | Thursday, 24 January 2013 19:31
Social sharing
Nevro in Menlo Park, Calif., a medical device company, has announced the issuance of four additional key patents related to the company's Senza(R) system and High-Frequency Spinal Cord Stimulation therapy.
The Senza system, which aims at providing relief from chronic pain, is available in Europe and Australia. It is presently undergoing investigation in a clinical trial in the United States.

More Articles on Pain Management:

Dr. Ritu Verma Joins American Spine
Georgia Rep. Tom Weldon to Sponsor Pain Clinic Regulation Bill
Prospira PainCare to Deploy Athenahealth's Cloud-Based & EHR Services

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months